We use cookies to understand how you use our site and to improve your experience.
This includes personalizing content and advertising.
By pressing "Accept All" or closing out of this banner, you consent to the use of all cookies and similar technologies and the sharing of information they collect with third parties.
You can reject marketing cookies by pressing "Deny Optional," but we still use essential, performance, and functional cookies.
In addition, whether you "Accept All," Deny Optional," click the X or otherwise continue to use the site, you accept our Privacy Policy and Terms of Service, revised from time to time.
You are being directed to ZacksTrade, a division of LBMZ Securities and licensed broker-dealer. ZacksTrade and Zacks.com are separate companies. The web link between the two companies is not a solicitation or offer to invest in a particular security or type of security. ZacksTrade does not endorse or adopt any particular investment strategy, any analyst opinion/rating/report or any approach to evaluating individual securities.
If you wish to go to ZacksTrade, click OK. If you do not, click Cancel.
Are Medical Stocks Lagging Boston Scientific (BSX) This Year?
Read MoreHide Full Article
For those looking to find strong Medical stocks, it is prudent to search for companies in the group that are outperforming their peers. Has Boston Scientific (BSX - Free Report) been one of those stocks this year? Let's take a closer look at the stock's year-to-date performance to find out.
Boston Scientific is a member of our Medical group, which includes 1024 different companies and currently sits at #4 in the Zacks Sector Rank. The Zacks Sector Rank includes 16 different groups and is listed in order from best to worst in terms of the average Zacks Rank of the individual companies within each of these sectors.
The Zacks Rank is a proven system that emphasizes earnings estimates and estimate revisions, highlighting a variety of stocks that are displaying the right characteristics to beat the market over the next one to three months. Boston Scientific is currently sporting a Zacks Rank of #2 (Buy).
Over the past 90 days, the Zacks Consensus Estimate for BSX's full-year earnings has moved 2.6% higher. This means that analyst sentiment is stronger and the stock's earnings outlook is improving.
Our latest available data shows that BSX has returned about 47.2% since the start of the calendar year. In comparison, Medical companies have returned an average of 5.6%. This means that Boston Scientific is outperforming the sector as a whole this year.
One other Medical stock that has outperformed the sector so far this year is Addex Therapeutics Ltd. Sponsored ADR (ADXN - Free Report) . The stock is up 91.1% year-to-date.
In Addex Therapeutics Ltd. Sponsored ADR's case, the consensus EPS estimate for the current year increased 183.1% over the past three months. The stock currently has a Zacks Rank #2 (Buy).
To break things down more, Boston Scientific belongs to the Medical - Products industry, a group that includes 88 individual companies and currently sits at #65 in the Zacks Industry Rank. Stocks in this group have gained about 13.9% so far this year, so BSX is performing better this group in terms of year-to-date returns.
In contrast, Addex Therapeutics Ltd. Sponsored ADR falls under the Medical - Drugs industry. Currently, this industry has 171 stocks and is ranked #81. Since the beginning of the year, the industry has moved -4.5%.
Investors with an interest in Medical stocks should continue to track Boston Scientific and Addex Therapeutics Ltd. Sponsored ADR. These stocks will be looking to continue their solid performance.
See More Zacks Research for These Tickers
Normally $25 each - click below to receive one report FREE:
Image: Bigstock
Are Medical Stocks Lagging Boston Scientific (BSX) This Year?
For those looking to find strong Medical stocks, it is prudent to search for companies in the group that are outperforming their peers. Has Boston Scientific (BSX - Free Report) been one of those stocks this year? Let's take a closer look at the stock's year-to-date performance to find out.
Boston Scientific is a member of our Medical group, which includes 1024 different companies and currently sits at #4 in the Zacks Sector Rank. The Zacks Sector Rank includes 16 different groups and is listed in order from best to worst in terms of the average Zacks Rank of the individual companies within each of these sectors.
The Zacks Rank is a proven system that emphasizes earnings estimates and estimate revisions, highlighting a variety of stocks that are displaying the right characteristics to beat the market over the next one to three months. Boston Scientific is currently sporting a Zacks Rank of #2 (Buy).
Over the past 90 days, the Zacks Consensus Estimate for BSX's full-year earnings has moved 2.6% higher. This means that analyst sentiment is stronger and the stock's earnings outlook is improving.
Our latest available data shows that BSX has returned about 47.2% since the start of the calendar year. In comparison, Medical companies have returned an average of 5.6%. This means that Boston Scientific is outperforming the sector as a whole this year.
One other Medical stock that has outperformed the sector so far this year is Addex Therapeutics Ltd. Sponsored ADR (ADXN - Free Report) . The stock is up 91.1% year-to-date.
In Addex Therapeutics Ltd. Sponsored ADR's case, the consensus EPS estimate for the current year increased 183.1% over the past three months. The stock currently has a Zacks Rank #2 (Buy).
To break things down more, Boston Scientific belongs to the Medical - Products industry, a group that includes 88 individual companies and currently sits at #65 in the Zacks Industry Rank. Stocks in this group have gained about 13.9% so far this year, so BSX is performing better this group in terms of year-to-date returns.
In contrast, Addex Therapeutics Ltd. Sponsored ADR falls under the Medical - Drugs industry. Currently, this industry has 171 stocks and is ranked #81. Since the beginning of the year, the industry has moved -4.5%.
Investors with an interest in Medical stocks should continue to track Boston Scientific and Addex Therapeutics Ltd. Sponsored ADR. These stocks will be looking to continue their solid performance.